Quarterly Results Results Snapshot
YoYQoQ
Figures in Million
Consolidate Quarterly Results
Dec'25
Sep'25
Jun'25
Mar'25
Dec'24
Sep'24
Jun'24
Net Sales
45.89
19.99
26.20
15.39
18.75
16.87
14.26
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
45.89
19.99
26.20
15.39
18.75
16.87
14.26
Raw Material Cost
1.51
1.41
1.35
1.38
1.36
1.56
1.56
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
0.58
0.57
0.66
0.64
0.64
0.63
0.64
Selling and Distribution Expenses
19.86
17.33
17.49
19.71
17.45
15.75
15.93
Other Expenses
0.64
0.71
0.94
1.04
0.85
0.82
0.89
Total Expenditure (Excl Depreciation)
28.33
26.45
28.92
32.13
27.95
26.14
27.01
Operating Profit (PBDIT) excl Other Income
17.6
-6.5
-2.7
-16.7
-9.200000000000001
-9.3
-12.8
Other Income
56.09
4.14
76.59
3.24
0.90
1.42
1.13
Operating Profit (PBDIT)
75.16
-0.91
75.22
-12.12
-6.93
-6.30
-10.07
Interest
0.58
0.57
0.66
0.64
0.64
0.63
0.64
Exceptional Items
0.00
0.00
0.00
0.00
0.00
-1.56
-2.95
Gross Profit (PBDT)
44.38
18.58
24.85
14.01
17.39
15.31
12.70
Depreciation
1.51
1.41
1.35
1.38
1.36
1.56
1.56
Profit Before Tax
73.07
-2.89
73.21
-14.14
-8.94
-10.05
-15.22
Tax
12.04
-6.50
18.37
-0.56
6.59
2.65
1.31
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
61.02
3.62
54.84
-13.58
-15.53
-12.70
-16.53
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
61.02
3.62
54.84
-13.58
-15.53
-12.70
-16.53
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
61.02
3.62
54.84
-13.58
-15.53
-12.70
-16.53
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
0.0
0.0
0.0
0.0
0.0
0.0
0.0
Reserves
296.72
232.68
224.85
165.98
175.54
185.65
193.69
Earnings per share (EPS)
1.15
0.07
1.08
-0.27
-0.31
-0.26
-0.34
Diluted Earnings per share
1.15
0.07
1.08
-0.27
-0.31
-0.26
-0.34
Operating Profit Margin (Excl OI)
38.28%
-32.29%
-10.4%
-108.77%
-49.06%
-54.99%
-89.46%
Gross Profit Margin
162.5%
-7.41%
284.62%
-82.92%
-40.4%
-50.36%
-95.84%
PAT Margin
132.98%
18.08%
209.33%
-88.24%
-82.8%
-75.28%
-115.94%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - YoY
Net Sales
YoY Growth in quarter ended Dec 2025 is 144.15% vs 6.82% in Dec 2024
Consolidate Net Profit
YoY Growth in quarter ended Dec 2025 is 493.55% vs -82.35% in Dec 2024
Operating Profit (PBDIT) excl Other Income
YoY Growth in quarter ended Dec 2025 is 344.87% vs -73.33% in Dec 2024
Interest
YoY Growth in quarter ended Dec 2025 is 0.00% vs 0.00% in Dec 2024
Operating Profit Margin (Excl OI)
YoY Growth in quarter ended Dec 2025 has improved from Dec 2024
Compare Quarterly Results Of Theravance Biopharma, Inc. With
Figures in Million
Consolidate Quarterly Results
Change(USD)
Change(%)
Net Sales
45.89
1.29
44.60
3,457.36%
Other Operating Income
0.00
0.00
0.00
Total Operating income
45.89
1.29
44.60
3,457.36%
Raw Material Cost
1.51
1.47
0.04
2.72%
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0.00
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
0.58
0.00
0.58
Selling and Distribution Expenses
19.86
5.58
14.28
255.91%
Other Expenses
0.64
1.66
-1.02
-61.45%
Total Expenditure (Excl Depreciation)
28.33
23.63
4.70
19.89%
Operating Profit (PBDIT) excl Other Income
17.56
-22.33
39.89
178.64%
Other Income
56.09
2.94
53.15
1,807.82%
Operating Profit (PBDIT)
75.16
-19.29
94.45
489.63%
Interest
0.58
0.00
0.58
Exceptional Items
0.00
-0.40
0.40
100.00%
Gross Profit (PBDT)
44.38
-0.17
44.55
26,205.88%
Depreciation
1.51
0.10
1.41
1,410.00%
Profit Before Tax
73.07
-19.80
92.87
469.04%
Tax
12.04
0.00
12.04
Provisions and contingencies
0
0
0.00
Profit After Tax
61.02
-19.80
80.82
408.18%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
61.02
-19.80
80.82
408.18%
Share in Profit of Associates
0
0
0.00
Minority Interest
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
Consolidated Net Profit
61.02
-19.80
80.82
408.18%
Equity Capital
0
0
0.00
Face Value
0.00
0.00
0.00
Reserves
296.72
103.08
193.64
187.85%
Earnings per share (EPS)
1.15
-0.16
1.31
818.75%
Diluted Earnings per share
1.15
-0.16
1.31
818.75%
Operating Profit Margin (Excl OI)
38.28%
-1,724.63%
0.00
1,762.91%
Gross Profit Margin
162.50%
-1,520.69%
0.00
1,683.19%
PAT Margin
132.98%
-1,528.57%
0.00
1,661.55%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Quarterly - Net Sales
Net Sales 4.59 Million
in Dec 2025Figures in Million
QoQ Growth in quarter ended Dec 2025 is 129.50% vs -23.66% in Sep 2025
YoY Growth in quarter ended Dec 2025 is 144.15% vs 6.82% in Dec 2024
Quarterly - Consolidate Net Profit
Consolidate Net Profit 6.10 Million
in Dec 2025Figures in Million
QoQ Growth in quarter ended Dec 2025 is 1,594.44% vs -93.43% in Sep 2025
YoY Growth in quarter ended Dec 2025 is 493.55% vs -82.35% in Dec 2024
Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 1.91 Million
in Dec 2025Figures in Million
QoQ Growth in quarter ended Dec 2025 is 482.00% vs -257.14% in Sep 2025
YoY Growth in quarter ended Dec 2025 is 344.87% vs -73.33% in Dec 2024
Quarterly - Interest
Interest 0.06 Million
in Dec 2025Figures in Million
QoQ Growth in quarter ended Dec 2025 is 0.00% vs -14.29% in Sep 2025
YoY Growth in quarter ended Dec 2025 is 0.00% vs 0.00% in Dec 2024
Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 38.28%
in Dec 2025Figures in %
QoQ Growth in quarter ended Dec 2025 has improved from Sep 2025
YoY Growth in quarter ended Dec 2025 has improved from Dec 2024
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
